{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:24:24Z","timestamp":1792110264610,"version":"4.4.0"},"reference-count":121,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The role of lipids is essential in any phase of the atherosclerotic process, which is considered a chronic lipid-related and inflammatory condition. The traditional lipid profile (including the evaluation of total cholesterol, triglycerides, high-density lipoprotein, and low-density lipoprotein) is a well-established tool to assess the risk of atherosclerosis and as such has been widely used as a pillar of cardiovascular disease prevention and as a target of pharmacological treatments in clinical practice over the last decades. However, other non-traditional lipids have emerged as possible alternative predictors of cardiometabolic risk in addition to traditional single or panel lipids, as they better reflect the overall interaction between lipid\/lipoprotein fractions. Therefore, this review deals with the lipid involvement characterizing the pathophysiology of atherosclerosis, discussing some recently proposed non-traditional lipid indices and, in the light of available knowledge, their actual potential as new additive tools to better stratify cardiovascular risk in patients with hyperlipidemia as well as possible therapeutic targets in the clinical practice.<\/jats:p>","DOI":"10.3390\/ijms24010075","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:28:55Z","timestamp":1671596935000},"page":"75","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":159,"title":["Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-502X","authenticated-orcid":false,"given":"Melania","family":"Gaggini","sequence":"first","affiliation":[{"name":"Institute of Clinical Physiology, National Research Council, Via Moruzzi 1, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4619-6227","authenticated-orcid":false,"given":"Francesca","family":"Gorini","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology, National Research Council, Via Moruzzi 1, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-6450","authenticated-orcid":false,"given":"Cristina","family":"Vassalle","sequence":"additional","affiliation":[{"name":"Fondazione CNR\u2014Regione Toscana G Monasterio, Via Moruzzi 1, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","article-title":"Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review","volume":"11","author":"Ralapanawa","year":"2021","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1042\/BST20220441","article-title":"The intracellular signaling pathways governing macrophage activation and function in human atherosclerosis","volume":"50","author":"Wilson","year":"2022","journal-title":"Biochem. Soc. Trans"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jakubiak, G.K., Pawlas, N., Cie\u015blar, G., and Stanek, A. (2021). Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182211970"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Poder, T.G., Erraji, J., Coulibaly, L.P., and Koffi, K. (2017). Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177476"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/JMDH.S254016","article-title":"Reflections on Atherosclerosis: Lesson from the Past and Future Research Directions","volume":"13","author":"Minelli","year":"2020","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014An Inflammatory Disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20417314221088508","DOI":"10.1177\/20417314221088509","article-title":"Recent Advance in Treatment of Atherosclerosis: Key Targets and Plaque-Positioned Delivery Strategies","volume":"13","author":"Li","year":"2022","journal-title":"J. Tissue Eng."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-018-0715-0","article-title":"The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis","volume":"20","author":"Pirillo","year":"2018","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.annepidem.2005.01.005","article-title":"A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region","volume":"15","author":"Barzi","year":"2005","journal-title":"Ann. Epidemiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","article-title":"Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses","volume":"50","year":"2019","journal-title":"Arch. Med. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Malekmohammad, K., Sewell, R.D., and Rafieian-Kopaei, M. (2019). Antioxidants and Atherosclerosis: Mechanistic Aspects. Biomolecules, 9.","DOI":"10.3390\/biom9080301"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/jn\/135.5.969","article-title":"Nutritional, Dietary and Postprandial Oxidative Stress","volume":"135","author":"Sies","year":"2005","journal-title":"J. Nutr."},{"key":"ref_13","unstructured":"Venugopal, S.K., Anoruo, M., and Jialal, I. (2022, December 15). Biochemistry, Low Density Lipoprotein. Available online: https:\/\/europepmc.org\/article\/NBK\/nbk500010."},{"key":"ref_14","unstructured":"Pirahanchi, Y., Sinawe, H., and Dimri, M. (2021). Biochemistry, LDL Cholesterol. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/HYPERTENSIONAHA.107.089854","article-title":"Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis","volume":"50","author":"Gleissner","year":"2007","journal-title":"Hypertension"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2016.05.013","article-title":"Physiology and Pathophysiology of OxLDL Uptake by Vascular Wall Cells in Atherosclerosis","volume":"84","author":"Formoso","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-016-0308-2","article-title":"Lipid Composition of Circulating Multiple-Modified Low Density Lipoprotein","volume":"15","author":"Zakiev","year":"2016","journal-title":"Lipids Health Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.crvasa.2016.10.003","article-title":"Circulating Desialylated Low Density Lipoprotein","volume":"59","author":"Orekhov","year":"2017","journal-title":"Cor. Vasa."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Wu, W.-K., Melnichenko, A.A., Wetzker, R., Sukhorukov, V., Markin, A.M., Khotina, V.A., and Orekhov, A.N. (2020). Signaling Pathways and Key Genes Involved in Regulation of Foam Cell Formation in Atherosclerosis. Cells, 9.","DOI":"10.3390\/cells9030584"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"707529","DOI":"10.3389\/fcvm.2021.707529","article-title":"Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms","volume":"8","author":"Malekmohammad","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/MOL.0b013e328357c933","article-title":"Electronegative Low-Density Lipoprotein. A Link between Apolipoprotein B Misfolding, Lipoprotein Aggregation and Proteoglycan Binding","volume":"23","author":"Villegas","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"714653","DOI":"10.1155\/2013\/714653","article-title":"The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts","volume":"2013","author":"Maiolino","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Summerhill, V.I., Grechko, A.V., Yet, S.-F., Sobenin, I.A., and Orekhov, A.N. (2019). The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143561"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.0007-1323.2001.01823.x","article-title":"Association between Plaque Instability, Angiogenesis and Symptomatic Carotid Occlusive Disease","volume":"88","author":"Mofidi","year":"2001","journal-title":"J. Br. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and Atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tcm.2018.09.017","article-title":"Atherosclerosis and Immunity: A Perspective","volume":"29","author":"Abdolmaleki","year":"2019","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"152786","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and Atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediators Inflamm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2009.01.002","article-title":"OxLDL Uptake by Dendritic Cells Induces Upregulation of Scavenger-Receptors, Maturation and Differentiation","volume":"205","author":"Nickel","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_29","unstructured":"Linton, M.F., Yancey, P.G., Davies, S.S., Jerome, W.G., Linton, E.F., Song, W.L., Doran, A.C., and Vickers, K.C. (2019). The Role of Lipids and Lipoproteins in Atherosclerosis. Endotext Internet, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK343489\/."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tcm.2005.11.003","article-title":"Platelet-Derived Growth Factor-BB Transactivates the Fibroblast Growth Factor Receptor to Induce Proliferation in Human Smooth Muscle Cells","volume":"16","author":"Millette","year":"2006","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcmg.2017.03.005","article-title":"Coronary Artery Calcification: From Mechanism to Molecular Imaging","volume":"10","author":"Nakahara","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.acc.2019.08.002","article-title":"Vascular and Valvular Calcification Biomarkers","volume":"95","author":"Clemente","year":"2020","journal-title":"Adv. Clin. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrcardio.2011.91","article-title":"Arterial Thrombus Formation in Cardiovascular Disease","volume":"8","author":"Lippi","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.10.009","article-title":"Lipoproteins as Modulators of Atherothrombosis: From Endothelial Function to Primary and Secondary Coagulation","volume":"82","author":"Ouweneel","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mu\u0107ka, S., Miodo\u0144ska, M., Jakubiak, G.K., Starzak, M., Cie\u015blar, G., and Stanek, A. (2022). Endothelial Function Assessment by Flow-Mediated Dilation Method: A Valuable Tool in the Evaluation of the Cardiovascular System. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191811242"},{"key":"ref_36","first-page":"471","article-title":"Endothelial and microvascular function in liver cirrhosis: An old concept that needs re-evaluation?","volume":"35","author":"Papagiouvanni","year":"2022","journal-title":"Ann. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/ATVBAHA.111.226100","article-title":"Triglycerides and Heart Disease: Still a Hypothesis?","volume":"31","author":"Goldberg","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New Insights into the Pathophysiology of Dyslipidemia in Type 2 Diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","article-title":"Beyond Low-Density Lipoprotein Cholesterol: Respective Contributions of Non\u2013High-Density Lipoprotein Cholesterol Levels, Triglycerides, and the Total Cholesterol\/High-Density Lipoprotein Cholesterol Ratio to Coronary Heart Disease Risk in Apparently Healthy Men and Women","volume":"55","author":"Arsenault","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"P\u0142aczkowska, S., So\u0142kiewicz, K., Bednarz-Misa, I., and Kratz, E.M. (2022). Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095089"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-01208-8","article-title":"The Sensibility of the New Blood Lipid Indicator Atherogenic Index of Plasma (AIP) in Menopausal Women with Coronary Artery Disease","volume":"19","author":"Guo","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the Special Contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual Cardiovascular Risk despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/nyas.13984","article-title":"Targeting LOX-1 in atherosclerosis and vasculopathy: Current knowledge and future perspectives","volume":"1443","author":"Tian","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"674103","DOI":"10.3389\/fcell.2021.674103","article-title":"Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive Review","volume":"9","author":"Varghese","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zingg, J.M., Vlad, A., and Ricciarelli, R. (2021). Oxidized LDLs as Signaling Molecules. Antioxidants, 10.","DOI":"10.3390\/antiox10081184"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.cjca.2017.07.015","article-title":"Association Between Circulating Oxidized LDL and Atherosclerotic Cardiovascular Disease: A Meta-analysis of Observational Studies","volume":"33","author":"Gao","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.5551\/jat.43299","article-title":"Circulating Oxidized Low-Density Lipoprotein Levels Independently Predict 10-Year Progression of Subclinical Carotid Atherosclerosis: A Community-Based Cohort Study","volume":"25","author":"Gao","year":"2018","journal-title":"J. Atheroscler Thromb."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7850659","DOI":"10.1155\/2022\/7850659","article-title":"The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis","volume":"2022","author":"Jamialahmadi","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.dsx.2018.08.036","article-title":"Beyond LDL-c: The importance of serum oxidized LDL in predicting risk for type 2 diabetes in the middle-aged Asian Indians","volume":"13","author":"Banerjee","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.104.529297","article-title":"Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population","volume":"112","author":"Meisinger","year":"2005","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.ATV.0000033829.14012.18","article-title":"Oxidized LDL in carotid plaques and plasma associates with plaque instability","volume":"22","author":"Nishi","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tcm.2018.05.010","article-title":"Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis\u2014Novel insights and future directions in diagnosis and therapy","volume":"29","author":"Hartley","year":"2019","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Jakubiak, G.K., Cie\u015blar, G., and Stanek, A. (2022). Nitrotyrosine, Nitrated Lipoproteins, and Cardio-vascular Dysfunction in Patients with Type 2 Diabetes: What Do We Know and What Remains to Be Explained?. Antioxidants, 11.","DOI":"10.3390\/antiox11050856"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lee, C.-K., Liao, C.-W., Meng, S.-W., Wu, W.-K., Chiang, J.-Y., and Wu, M.-S. (2021). Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080985"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of Triglyceride-Lowering LPL Variants and LDL\u2013Lowering LDLR Variants with Risk of Coronary Heart Disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"European Atherosclerosis Society Consensus Panel. The Polygenic Nature of Hypertriglyceridaemia: Implications for Definition, Diagnosis, and Management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","article-title":"Cardiovascular Disease Risk Reduction by Raising HDL Cholesterol\u2013Current Therapies and Future Opportunities","volume":"167","author":"Ali","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_60","first-page":"28","article-title":"Non-HDL Cholesterol as a Therapeutic Goal","volume":"31","author":"Brea","year":"2019","journal-title":"Clin. Investig. Arterioscler."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11883-011-0224-x","article-title":"The Role of Non-HDL Cholesterol in Risk Stratification for Coronary Artery Disease","volume":"14","author":"Rana","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(19)32519-X","article-title":"Application of Non-HDL Cholesterol for Population-Based Cardiovascular Risk Stratification: Results from the Multinational Cardiovascular Risk Consortium","volume":"394","author":"Brunner","year":"2019","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/STROKEAHA.120.030783","article-title":"Non\u2013High-Density Lipoprotein Cholesterol Predicts Adverse Outcomes in Acute Ischemic Stroke","volume":"52","author":"Wang","year":"2021","journal-title":"Stroke"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-10-46","article-title":"Serum Non-High-Density Lipoprotein Cholesterol Concentration and Risk of Death from Cardiovascular Diseases among US Adults with Diagnosed Diabetes: The Third National Health and Nutrition Examination Survey Linked Mortality Study","volume":"10","author":"Li","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cca.2017.05.006","article-title":"Meta-Analysis of Serum Non-High-Density Lipoprotein Cholesterol and Risk of Coronary Heart Disease in the General Population","volume":"471","author":"Liu","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e011433","DOI":"10.1161\/JAHA.118.011433","article-title":"Trajectories of Blood Lipid Concentrations over the Adult Life Course and Risk of Cardiovascular Disease and All-cause Mortality: Observations from the Framingham Study over 35 Years","volume":"8","author":"Duncan","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","article-title":"Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease","volume":"131","author":"Peterson","year":"2015","journal-title":"Circulation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijcard.2016.10.106","article-title":"Prognostic Value of Non-High-Density Lipoprotein Cholesterol for Mortality in Patients with Coronary Heart Disease: A Systematic Reviewemnant cholesterol and myocardial infarction in normal weight, overweight, and obese individuals from the Copenhagen General Population Study and Meta-Analysis","volume":"227","author":"Liao","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL Cholesterol, Non\u2013HDL Cholesterol, and Apolipoprotein B Levels with Risk of Cardiovascular Events among Patients Treated with Statins: A Meta-Analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41440-019-0251-5","article-title":"Associations of non-high-density are effective lipoprotein cholesterol, triglycerides and the total cholesterol\/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population","volume":"42","author":"We","year":"2019","journal-title":"Hypertens. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.amjcard.2013.05.049","article-title":"Iwate-Kenco Study Group. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg\/dl","volume":"112","author":"Tanaka","year":"2013","journal-title":"Am J Cardiol"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.amjcard.2006.06.032","article-title":"Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease","volume":"98","author":"Liu","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MED.0000000000000714","article-title":"New targets for treating hypertriglyceridemia","volume":"29","author":"Parhofer","year":"2022","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pathol.2018.11.006","article-title":"Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment","volume":"51","author":"Carr","year":"2019","journal-title":"Pathology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MED.0000000000000619","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease risk: Current status and treatments","volume":"28","year":"2021","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","article-title":"Apo B versus Cholesterol in Estimating Cardiovascular Risk and in Guiding Therapy: Report of the Thirty-person\/Ten-country Panel","volume":"259","author":"Barter","year":"2006","journal-title":"J. Intern. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.amjcard.2012.07.007","article-title":"Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials","volume":"110","author":"Robinson","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2008.10.024","article-title":"Meta-Analysis of the Relationship between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk","volume":"53","author":"Robinson","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_81","first-page":"e067731-74","article-title":"Comparative Effectiveness of Statins on Non-High Density Lipoprotein Cholesterol in People with Diabetes and at Risk of Cardiovascular Disease: Systematic Review and Network Meta-Analysis","volume":"376","author":"Hodkinson","year":"2022","journal-title":"BMJ"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jacc.2019.04.047","article-title":"Trajectories of Non\u2013HDL Cholesterol across Midlife: Implications for Cardiovascular Prevention","volume":"74","author":"Pencina","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamacardio.2020.7238","article-title":"Association of Non-High-Density Lipoprotein Cholesterol Measured in Adolescence, Young Adulthood, and Mid-Adulthood With Coronary Artery Calcification Measured in Mid-Adulthood","volume":"6","author":"Armstrong","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.CIR.67.4.730","article-title":"Summary Estimates of Cholesterol Used to Predict Coronary Heart Disease","volume":"67","author":"Castelli","year":"1983","journal-title":"Circulation"},{"key":"ref_85","first-page":"757","article-title":"Lipoprotein Ratios: Physiological Significance and Clinical Usefulness in Cardiovascular Prevention","volume":"5","author":"Pallardo","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2017.04.009","article-title":"Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Troms\u00f8 Study 1979\u20132012","volume":"261","author":"Albrektsen","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0002-9149(03)00319-9","article-title":"Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study)","volume":"91","author":"Langer","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kouvari, M., Panagiotakos, D.B., Chrysohoou, C., Georgousopoulou, E.N., Tousoulis, D., and Pitsavos, C. (2020). Sex-Related Differences of the Effect of Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk; Insights from the ATTICA Study (2002\u20132012). Molecules, 25.","DOI":"10.3390\/molecules25071506"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-022-03087-8","article-title":"Insulin Resistance and Cardiometabolic Indexes: Comparison of Concordance in Working-Age Subjects with Overweight and Obesity","volume":"77","author":"Vigna","year":"2022","journal-title":"Endocrine"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/archinte.161.22.2685","article-title":"Total Cholesterol\/HDL Cholesterol Ratio vrequiring extensive reorganization and re-writings LDL Cholesterol\/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men: The Quebec Cardiovascular Study","volume":"161","author":"Lemieux","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"ref_91","first-page":"359","article-title":"Atherogenic Index of Plasma, Castelli Risk Index and Atherogenic Coefficient-New Parameters in Assessing Cardiovascular Risk","volume":"3","author":"Bhardwaj","year":"2013","journal-title":"Int. J. Pharm. Biol. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1751-7141.2008.00011.x","article-title":"Association of Total Cholesterol\/High-density Lipoprotein Cholesterol Ratio with Proximal Coronary Atherosclerosis Detected by Multislice Computed Tomography","volume":"12","author":"Nair","year":"2009","journal-title":"Prev. Cardiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/VHRM.S104369","article-title":"Triglyceride-Rich Lipoproteins as a Causal Factor for Cardiovascular Disease","volume":"12","author":"Toth","year":"2016","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant Cholesterol, Not LDL Cholesterol, Is Associated with Incident Cardiovascular Disease","volume":"76","author":"Subirana","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e002765","DOI":"10.1161\/JAHA.115.002765","article-title":"Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies","volume":"5","author":"Joshi","year":"2016","journal-title":"J Am Heart Assoc."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2011.04.040","article-title":"Predictive Value of Remnant Lipoprotein for Cardiovascular Events in Patients with Coronary Artery Disease after Achievement of LDLholesterol Goals","volume":"218","author":"Nakamura","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1373\/clinchem.2014.234146","article-title":"Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population","volume":"61","author":"Varbo","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1373\/clinchem.2015.253757","article-title":"Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease","volume":"62","author":"Jepsen","year":"2016","journal-title":"Clin. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2021.06.907","article-title":"Association of Triglyceride-Rich Lipoprotein-Cholesterol with Recurrent Cardiovascular Events in Statin-Treated Patients According to Different Inflammatory Status","volume":"330","author":"Liu","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5551\/jat.E598","article-title":"Remnant lipoproteins as strong key particles to atherogenesis","volume":"16","author":"Fujioka","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-019-1080-x","article-title":"Evidence for Changing Lipid Management Strategy to Focus on Non-High Density Lipoprotein Cholesterol","volume":"18","author":"Su","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1038\/s41598-021-89307-z","article-title":"Atherogenic index of plasma as predictors for metabolic syndrome, hy-pertension and diabetes mellitus in Taiwan citizens: A 9-year longitudinal study","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"175","DOI":"10.33314\/jnhrc.v16i2.1570","article-title":"Atherogenic Index of Plasma in Postmenopausal Women","volume":"16","author":"Khakurel","year":"2018","journal-title":"J. Nepal. Health Res. Counc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e8058","DOI":"10.1097\/MD.0000000000008058","article-title":"The atherogenic index of plasma is a strong and independent predictor for coronary artery dis-ease in the Chinese Han population","volume":"96","author":"Cai","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref_106","first-page":"106","article-title":"Low Plasma Atherogenic Index Associated with Poor Prognosis in Hospitalized Patients with Acute Myocardial Infarction","volume":"48","author":"Hartopo","year":"2016","journal-title":"Acta Medica Indones."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Shin, H.R., Song, S., Cho, J.A., and Ly, S.Y. (2022). Atherogenic Index of Plasma and Its Association with Risk Factors of Coronary Artery Disease and Nutrient Intake in Korean Adult Men: The 2013\u20132014 KNHANES. Nutrients, 14.","DOI":"10.3390\/nu14051071"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1765835","DOI":"10.1155\/2018\/1765835","article-title":"Atherogenic Index in Type 2 Diabetes and Its Relationship with Chronic Microvascular Complications","volume":"2018","author":"Li","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-020-0989-8","article-title":"The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: Results from an observational cohort study in China","volume":"19","author":"Qin","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/00033197211012129","article-title":"The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients with Type 2 Diabetes","volume":"72","author":"Zhou","year":"2021","journal-title":"Angiology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MCA.0000000000001166","article-title":"Atherogenic index of plasma predicts coronary artery disease severity and major adverse cardiac events in absence of conventional risk factors","volume":"33","author":"Mangalesh","year":"2022","journal-title":"Coron. Artery Dis."},{"key":"ref_112","first-page":"33197221080911","article-title":"Association of Atherogenic Index of Plasma With Angiographic Progression in Patients With Suspected Coronary Artery Disease","volume":"1","author":"Shui","year":"2022","journal-title":"Angiology"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Zhan, Y., Xu, T., and Tan, X. (2016). Two parameters reflect lipid-driven inflammatory state in acute coronary syndrome: Atherogenic index of plasma, neutrophil-lymphocyte ratio. BMC Cardiovasc. Disord., 16.","DOI":"10.1186\/s12872-016-0274-7"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1373\/clinchem.2017.279463","article-title":"Remnant cholesterol and myocardial infarction in normal weight, overweight, and obese individuals from the Copenhagen General Population Study","volume":"64","author":"Varbo","year":"2018","journal-title":"Clin. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1161\/01.CIR.0000038496.57570.06","article-title":"Non\u2013High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI)","volume":"106","author":"Bittner","year":"2002","journal-title":"Circulation"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","article-title":"Is There a Simple Way to Identify Insulin-Resistant Individuals at Increased Risk of Cardiovascular Disease?","volume":"96","author":"McLaughlin","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.103.15.1949","article-title":"Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: The Limone sul Garda study","volume":"103","author":"Sirtori","year":"2001","journal-title":"Circulation"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/bi011716p","article-title":"Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I","volume":"41","author":"Bielicki","year":"2002","journal-title":"Biochemistry"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.14336\/AD.2019.1025","article-title":"Trends in LDL and Non-HDL Levels with Age","volume":"11","author":"Zhang","year":"2020","journal-title":"Aging Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","article-title":"Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/75\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:45:10Z","timestamp":1760147110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24010075"],"URL":"https:\/\/doi.org\/10.3390\/ijms24010075","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]}}}